Firm at a glance
BlackPeak Capital is a platform private equity firm founded in 2014, per its own website [S1].
What they buy
BlackPeak Capital’s portfolio reflects activity across manufacturing, software, healthcare, IT services, and business services sectors, per publicly disclosed holdings [S2]. The firm’s observed investments span biotechnology manufacturing, software platforms, healthcare providers, and industrial manufacturing operations [S2]. The firm reports approximately EUR 150 million in total assets under management across two funds as of early 2025 [S1].
Portfolio
Manufacturing
Fasal Bio (acquired April 2026) [S2], Walltopia [S2], and International Power Supply [S2].
Software and IT Services
Alcatraz (acquired April 2026) [S2] and Software Group [S2].
Healthcare
Affinity Life Care (acquired August 2025) [S2] and Humanita [S2].
Business Services
Resalta [S2].
Recent activity (last 24 months)
– **April 2026**: Acquisition of Fasal Bio [S3]
– **April 2026**: Acquisition of Alcatraz [S3]
– **December 2025**: Exit of euShipments.com [S3]
– **August 2025**: Acquisition of Affinity Life Care [S3]
How this firm fits a seller
BlackPeak Capital’s transaction history demonstrates both acquisition and exit activity, with the December 2025 sale of euShipments.com indicating active portfolio turnover [S3]. The firm’s current fund vintage dates to 2021, per public sources [S1]. For owner-operators in manufacturing, software, healthcare, or business services sectors, the firm’s portfolio composition suggests potential fit, though specific investment criteria are not publicly detailed. The firm’s recent pace of three acquisitions and one exit within 24 months indicates ongoing deal activity [S3].
Sources
[S1] https://www.blackpeak-capital.com/about (as of 2025-01-15)
[S2] https://www.blackpeak-capital.com/companies (as of 2025-01-15)
[S3] https://www.blackpeak-capital.com/news (as of 2025-01-15)
Frequently asked questions
Does BlackPeak Capital buy manufacturing businesses?
Yes, manufacturing represents a significant portion of the firm’s portfolio. BlackPeak Capital’s publicly disclosed holdings include Fasal Bio (acquired April 2026), Walltopia, and International Power Supply, all categorized as manufacturing operations [S2].
What companies has BlackPeak Capital acquired recently?
The firm’s most recent acquisitions include Fasal Bio in April 2026, Alcatraz (software sector) in April 2026, and Affinity Life Care (healthcare) in August 2025, per public transaction records [S3].
Where is BlackPeak Capital based and how big is the firm?
The firm reports approximately EUR 150 million in total assets under management across two funds, with its current fund vintage dating to 2021 [S1]. Specific office locations are not disclosed in publicly available materials reviewed as of January 2025.
Is BlackPeak Capital still actively acquiring?
Yes, the firm completed two acquisitions in April 2026 (Fasal Bio and Alcatraz), indicating active deal execution as of recent months [S3].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.